Skip to Content

G 0533 G 0533 (Fenofibrate (micronized) 200 mg)

Pill imprint G 0533 G 0533 has been identified as Fenofibrate (micronized) 200 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fenofibrate (micronized) 200 mg G 0533 G 0533
Fenofibrate (micronized) 200 mg G 0533 G 0533 Front
Fenofibrate (micronized) 200 mg G 0533 G 0533 Back
Fenofibrate (micronized) 200 mg G 0533 G 0533
Fenofibrate (micronized)
G 0533
G 0533
200 mg
19.00 mm
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Global Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5575 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.